dymista 137+50 mikrog/dosis næsespray, suspension
2care4 aps - azelastinhydrochlorid, fluticasonpropionat - næsespray, suspension - 137+50 mikrog/dosis
grazax 75.000 sq.t frysetørret tablet
orifarm a/s - eng-rottehale - frysetørret tablet - 75.000 sq.t
dymista 137+50 mikrog/dosis næsespray, suspension
paranova danmark a/s - azelastinhydrochlorid, fluticasonpropionat - næsespray, suspension - 137+50 mikrog/dosis
biresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
duoresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
alk (552) hesteskæl 100.000 sq-u/ml injektionsvæske, alutard-sq
alk-abello a/s - hesteskæl - injektionsvæske, alutard-sq - 100.000 sq-u/ml
alk (553) hundehår 450.000 sq-u/htgl injektionssubstans (aquagen-sq)
alk-abello a/s - hundehår - injektionssubstans (aquagen-sq) - 450.000 sq-u/htgl
alk (553) hundehår 100.000 sq-u/ml injektionsvæske, suspension
alk-abello a/s - hundehår - injektionsvæske, suspension - 100.000 sq-u/ml
alk (555) kattehår 450.000 sq-u/htgl injektionssubstans (aquagen-sq)
alk-abello a/s - kattehår - injektionssubstans (aquagen-sq) - 450.000 sq-u/htgl
alk (555) kattehår 100.000 sq-u/ml injektionsvæske, alutard-sq
alk-abello a/s - kattehår - injektionsvæske, alutard-sq - 100.000 sq-u/ml